In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines.

J Nanobiotechnology · 2011 · PMC3281789 · PMID 22185583

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The reduced immunogenicity of drug-carrying phages should allow a number of sequential treatments (repeat therapy) without severe side effects that is highly significant for anti-bacterial treatments.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.